Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 247-255, June 2005

Brain metastasis of unknown primary: A diagnostic and therapeutic dilemma

  • Konstantinos S. Polyzoidis

      Affiliations

    • Department of Neurosurgery, Medical School, University of Ioannina, P.O. Box 1186, Post code 45110, Ioannina, Greece
    • Corresponding Author InformationCorresponding author. Tel.: 0030 26510 97527; fax: 0030 26510 97030
  • ,
  • George Miliaras

      Affiliations

    • Department of Neurosurgery, Medical School, University of Ioannina, P.O. Box 1186, Post code 45110, Ioannina, Greece
    • Tel.: 0030 26510 97527; fax: 0030 26510 97030.
  • ,
  • Nicholas Pavlidis

      Affiliations

    • Department of Medical Oncology, Medical School, University of Ioannina, Post code 45110, Ioannina, Greece
    • Tel./fax: 0030 26510 99394.

published online 23 May 2005.

summary 

The diagnosis of a brain metastasis is usually made during the routine follow up examinations of patients with known cancer, who are under the care of oncology departments. The involvement of the neurosurgeon depends on the philosophy and referral patterns of each oncology group. Patients with brain metastases of unknown primary (BMUP) are much more likely to seek the help of a neurosurgeon or a neurologist before contacting an oncologist, because the presenting clinical features originate from the brain. BMUPs are almost equal in numbers to brain primaries and differ from regular cerebral metastases regarding their site of origin, which will remain unknown in about 50% despite vigorous investigation. The clinical picture is similar to that of primary brain tumours but they seem to show different areas of predilection in the brain parenchyma. By reviewing the literature we are presenting the epidemiology, clinical presentation, diagnostic workup and treatment plan for this group of patients.

Keywords: Brain metastasis, Unknown primary, Diagnosis, Therapy, Prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(05)00056-3

doi:10.1016/j.ctrv.2005.03.006

Cancer Treatment Reviews
Volume 31, Issue 4 , Pages 247-255, June 2005